BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19387611)

  • 1. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?
    Sabanayagam C; Liew G; Tai ES; Shankar A; Lim SC; Subramaniam T; Wong TY
    Diabetologia; 2009 Jul; 52(7):1279-89. PubMed ID: 19387611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of macro- and microvascular complications in patients with type 2 diabetes and kidney disease with or without albuminuria in a single Chinese Diabetes Centre.
    Wu D; Xuan Y; Ruan Y; Feng X; Zhu Y; Jia C; Liu J; Li H; Li L; Dong X
    Diab Vasc Dis Res; 2016 Jan; 13(1):21-30. PubMed ID: 26499917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.
    Pradeepa R; Anjana RM; Unnikrishnan R; Ganesan A; Mohan V; Rema M
    Diabetes Technol Ther; 2010 Oct; 12(10):755-61. PubMed ID: 20818974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial.
    Maple-Brown LJ; Ye C; Retnakaran R
    Diabet Med; 2013 Jan; 30(1):95-9. PubMed ID: 22937915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
    Johnson L; Rayner B
    Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).
    Raman R; Gupta A; Krishna S; Kulothungan V; Sharma T
    J Diabetes Complications; 2012; 26(2):123-8. PubMed ID: 22446033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program.
    Nang EE; Khoo CM; Tai ES; Lim SC; Tavintharan S; Wong TY; Heng D; Lee J
    Am J Epidemiol; 2009 Jun; 169(12):1454-62. PubMed ID: 19406920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus.
    Klein R; Klein BE; Moss SE
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):90-6. PubMed ID: 8554220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No ethnic differences in the association of glycated hemoglobin with retinopathy: the national health and nutrition examination survey 2005-2008.
    Bower JK; Brancati FL; Selvin E
    Diabetes Care; 2013 Mar; 36(3):569-73. PubMed ID: 23069841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
    Bennett CM; Guo M; Dharmage SC
    Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2002 May; 287(19):2563-9. PubMed ID: 12020338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
    Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
    Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia.
    Tapp RJ; Zimmet PZ; Harper CA; de Courten MP; McCarty DJ; Balkau B; Taylor HR; Welborn TA; Shaw JE;
    Diabetes Res Clin Pract; 2006 Sep; 73(3):315-21. PubMed ID: 16644057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes.
    Selvin E; Ning Y; Steffes MW; Bash LD; Klein R; Wong TY; Astor BC; Sharrett AR; Brancati FL; Coresh J
    Diabetes; 2011 Jan; 60(1):298-305. PubMed ID: 20978092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of diabetes mellitus using HbA1c in Asians: relationship between HbA1c and retinopathy in a multiethnic Asian population.
    Sabanayagam C; Khoo EY; Lye WK; Ikram MK; Lamoureux EL; Cheng CY; Tan ML; Salim A; Lee J; Lim SC; Tavintharan S; Thai AC; Heng D; Ma S; Tai ES; Wong TY
    J Clin Endocrinol Metab; 2015 Feb; 100(2):689-96. PubMed ID: 25375980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
    Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Selvin E; Steffes M; Coresh J; Astor BC
    Arch Intern Med; 2008 Dec; 168(22):2440-7. PubMed ID: 19064828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.